Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimester
- 25 April 2014
- journal article
- review article
- Published by Wiley in Prenatal Diagnosis
- Vol. 34 (7) , 635-641
Abstract
Second trimester biomarkers were initially introduced with the intent of screening for neural tube defects and then subsequently for Down syndrome. It was soon realized that these markers can be indirect evidence of abnormal placentation and, therefore, can be used for screening for adverse pregnancy outcomes. Several new biomarkers have subsequently been described with conflicting findings regarding their efficiency for screening for adverse pregnancy outcomes. Although a biologically feasible mechanism has been proposed for the role of these biomarkers, they still fall short of an ideal screening test to be clinically useful. © 2014 John Wiley & Sons, Ltd.Keywords
This publication has 76 references indexed in Scilit:
- Circulating Angiogenic Factors in the Pathogenesis and Prediction of PreeclampsiaHypertension, 2005
- Abnormal multiple marker screens are associated with adverse perinatal outcomes in cases of intrauterine growth restrictionAmerican Journal of Obstetrics and Gynecology, 2004
- ADAM 12-S Cleaves IGFBP-3 and IGFBP-5 and Is Inhibited by TIMP-3Biochemical and Biophysical Research Communications, 2000
- Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcomePrenatal Diagnosis, 2000
- Correlation Between Second Trimester Maternal Serum Inhibin-A and Human Chorionic Gonadotrophin for the Prediction of Pre-eclampsiaPlacenta, 2000
- Second-Trimester Serum Chorionic Gonadotropin Concentrations and Complications and Outcome of PregnancyNew England Journal of Medicine, 1999
- Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free β‐human chorionic gonadotropinUltrasound in Obstetrics & Gynecology, 1999
- Unexplained Elevations of Maternal Serum Alpha-FetoproteinObstetrical & Gynecological Survey, 1990
- Uterine artery Doppler in the investigatioin of pregnancies with raised maternal serum alphafetoproteinBJOG: An International Journal of Obstetrics & Gynaecology, 1990
- Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndromeBJOG: An International Journal of Obstetrics & Gynaecology, 1988